{
  "benchmark_name": "UPenn-GBM IDH1 Status Classification",
  "dataset": "UPenn-GBM",
  "task_type": "binary_classification",
  "description": "Classify IDH1 mutation status in glioblastoma patients",
  "focus_modalities": ["T1", "T2"],
  "evaluation_metrics": ["accuracy", "auc", "f1_score", "precision", "recall"],
  "modalities": {
    "T1": {
      "wandb_project": "july_stratified_upenn_gbm_idh1_status_single_t1",
      "wandb_url": "https://microsoft-research.wandb.io/t-jiachentu/july_stratified_upenn_gbm_idh1_status_single_t1",
      "priority": 1,
      "notes": "T1-weighted imaging without contrast"
    },
    "T2": {
      "wandb_project": "july_stratified_upenn_gbm_idh1_status_single_t2",
      "wandb_url": "https://microsoft-research.wandb.io/t-jiachentu/july_stratified_upenn_gbm_idh1_status_single_t2",
      "priority": 1,
      "notes": "T2-weighted imaging"
    }
  },
  "clinical_significance": "IDH1 mutation status is an important molecular marker for glioblastoma classification and prognosis",
  "dataset_splits": {
    "train": "stratified",
    "validation": "stratified",
    "test": "stratified"
  }
}